{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:15:52Z","timestamp":1790842552834,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1002\/jps.22528","type":"journal-article","created":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T23:57:24Z","timestamp":1299023844000},"page":"3139-3145","source":"Crossref","is-referenced-by-count":32,"title":["Upregulation of Endogenous Neurotrophin Levels in the Brain by Intranasal Administration of Carnosic Acid"],"prefix":"10.1016","volume":"100","author":[{"given":"Siva Ram Kiran","family":"Vaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Narasimha","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Repka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.22528_bb0010","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2165\/00003088-200140120-00003","article-title":"Delivery of neurotrophic factors to the central nervous system: Pharmacokinetic considerations","volume":"40","author":"Thorne","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jps.22528_bb0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2990.2003.00487.x","article-title":"Neurotrophins and neurodegeneration","volume":"29","author":"Dawbarn","year":"2003","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1002\/jps.22528_bb0020","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.1073\/pnas.82.22.7777","article-title":"Nerve growth factor promotes cholinergic development in brain striatal cultures","volume":"82","author":"Martinez","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/jps.22528_bb0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainresrev.2008.07.007","article-title":"New insights into brain BDNF function in normal aging and Alzheimer disease","volume":"59","author":"Tapia\u2010Arancibia","year":"2008","journal-title":"Brain Res Rev"},{"key":"10.1002\/jps.22528_bb0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q","article-title":"Clinicopathological findings following intraventricular glial\u2010derived neurotrophic factor treatment in a patient with Parkinson's disease","volume":"46","author":"Kordower","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1002\/jps.22528_bb0035","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.2174\/092986707781745578","article-title":"Neurotrophic factors\u2014A tool for therapeutic strategies in neurological, neuropsychiatric, and neuroimmunological diseases?","volume":"14","author":"Schulte\u2010Herbruggen","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1002\/jps.22528_bb0040","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1248\/bpb.26.1620","article-title":"Carnosic acid, a component of rosemary (Rosmarinus officinalis L.), promotes synthesis of nerve growth factor in T98G human glioblastoma cells","volume":"26","author":"Kosaka","year":"2003","journal-title":"Biol Pharm Bull"},{"key":"10.1002\/jps.22528_bb0045","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-4159.2007.05039.x","article-title":"Carnosic acid, a catechol\u2010type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1\/Nrf2 pathway via S\u2010alkylation of targeted cysteines on Keap1","volume":"104","author":"Satoh","year":"2008","journal-title":"J Neurochem"},{"key":"10.1002\/jps.22528_bb0050","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/WNR.0b013e32830abc1f","article-title":"Beneficial effects of carnosic acid on dieldrin\u2010induced dopaminergic neuronal cell death","volume":"19","author":"Park","year":"2008","journal-title":"Neuroreport"},{"key":"10.1002\/jps.22528_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/PL00005505","article-title":"Bioavailability of the antioxidative Rosmarinus officinalis compound carnosic acid in eggs","volume":"210","author":"Krause","year":"2000","journal-title":"Eur Food Res Technol"},{"key":"10.1002\/jps.22528_bb0060","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1016\/j.phytochem.2004.10.009","article-title":"Antibacterial and resistance modifying activity of Rosmarinus officinalis","volume":"65","author":"Oluwatuyi","year":"2004","journal-title":"Phytochemistry"},{"key":"10.1002\/jps.22528_bb0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/jat.1186","article-title":"Carnosic acid from rosemary extracts: A potential chemoprotective agent against aflatoxin B1. An in vitro study","volume":"27","author":"Costa","year":"2007","journal-title":"J Appl Toxicol"},{"key":"10.1002\/jps.22528_bb0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2006-957066","article-title":"Antiplatelet activity of carnosic acid, a phenolic diterpene from Rosmarinus officinalis","volume":"73","author":"Lee","year":"2007","journal-title":"Planta Med"},{"key":"10.1002\/jps.22528_bb0075","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/bmc.1184","article-title":"High\u2010performance liquid chromatography method for determination of carnosic acid in rat plasma and its application to pharmacokinetic study","volume":"23","author":"Yan","year":"2009","journal-title":"Biomed Chromatogr"},{"key":"10.1002\/jps.22528_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-5173(01)00761-X","article-title":"Cyclodextrins in topical drug formulations: Theory and practice","volume":"225","author":"Loftsson","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22528_bb0085","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/jps.2600840220","article-title":"Safety of parenteral hydroxypropyl\u2010\u03b2\u2010cyclodextrin","volume":"84","author":"Carpenter","year":"1995","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22528_bb0090","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/jps.21674","article-title":"Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake","volume":"98","author":"Vaka","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22528_bb0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10717549709051878","article-title":"Delivery of 125 I\u2010NGF to the brain via the olfactory route","volume":"4","author":"Frey","year":"1997","journal-title":"Drug Deliv"},{"key":"10.1002\/jps.22528_bb0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11481-006-9039-x","article-title":"Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuro AIDS","volume":"2","author":"Hanson","year":"2007","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1002\/jps.22528_bb0105","first-page":"117","article-title":"Phase\u2010solubility techniques","volume":"4","author":"Higuchi","year":"1965","journal-title":"Adv Anal Chem Instr"},{"key":"10.1002\/jps.22528_bb0110","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/jps.10226","article-title":"Self\u2010association and cyclodextrin solubilization of drugs","volume":"91","author":"Loftsson","year":"2002","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22528_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-5173(01)00895-X","article-title":"Cyclodextrins and drug permeability through semi\u2010permeable cellophane membranes","volume":"232","author":"Loftsson","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22528_bb0120","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/(SICI)1520-6017(200003)89:3<396::AID-JPS10>3.0.CO;2-F","article-title":"Validation of excised bovine nasal mucosa as in vitro model to study drug transport and metabolic pathways in nasal epithelium","volume":"89","author":"Schmidt","year":"2000","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22528_bb0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-5173(99)00030-7","article-title":"Effect of chitosan on epithelial permeability and structure","volume":"182","author":"Dodane","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22528_bb0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/B:PHAM.0000012150.60180.e3","article-title":"Effect of chitosan on epithelial cell tight junctions","volume":"21","author":"Smith","year":"2004","journal-title":"Pharm Res"},{"key":"10.1002\/jps.22528_bb0135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0014-5793(86)81028-6","article-title":"Aliphatic side chain of catecholamine potentiates the stimulatory effect of the catechol part on the synthesis of nerve growth factor","volume":"208","author":"Furukawa","year":"1986","journal-title":"FEBS Lett"},{"key":"10.1002\/jps.22528_bb0140","first-page":"373","article-title":"Intracerebral microdialysis in the study of physiology and behavior","volume":"4","author":"Young","year":"1996","journal-title":"Rev Neurosci"},{"key":"10.1002\/jps.22528_bb0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0166-4328(95)80001-8","article-title":"Brain microdialysis and its application for the study of animal behavior","volume":"70","author":"Westerink","year":"1995","journal-title":"Behav Brain Res"},{"key":"10.1002\/jps.22528_bb0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1615\/CritRevNeurobiol.v14.i2.30","article-title":"Applications of microdialysis methodology in nonhuman primates: Practice and rationale","volume":"14","author":"Bradberry","year":"2000","journal-title":"Crit Rev Neurobiol"},{"key":"10.1002\/jps.22528_bb0155","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1471-4159.2006.03765.x","article-title":"Microdialysis measures of functional increases in ACh release in the hippocampus with and without inclusion of acetylcholinesterase inhibitors in the perfusate","volume":"97","author":"Chang","year":"2006","journal-title":"J Neurochem"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915319894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915319894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T12:25:35Z","timestamp":1543926335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915319894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0022354915319894"],"URL":"https:\/\/doi.org\/10.1002\/jps.22528","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}